- Home
- RAPT vs CLIR Comparison
RAPT vs CLIR Comparison
Compare RAPT & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- CLIR
- Stock Information
- Founded
- RAPT 2015
- CLIR 2008
- Country
- RAPT United States
- CLIR United States
- Employees
- RAPT N/A
- CLIR N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- RAPT Health Care
- CLIR Industrials
- Exchange
- RAPT Nasdaq
- CLIR Nasdaq
- Market Cap
- RAPT 59.1M
- CLIR 59.3M
- IPO Year
- RAPT 2019
- CLIR 2012
- Fundamental
- Price
- RAPT $1.20
- CLIR $1.51
- Analyst Decision
- RAPT Hold
- CLIR Strong Buy
- Analyst Count
- RAPT 10
- CLIR 1
- Target Price
- RAPT $6.00
- CLIR $6.00
- AVG Volume (30 Days)
- RAPT 9.1M
- CLIR 193.6K
- Earning Date
- RAPT 03-06-2025
- CLIR 11-14-2024
- Dividend Yield
- RAPT N/A
- CLIR N/A
- EPS Growth
- RAPT N/A
- CLIR N/A
- EPS
- RAPT N/A
- CLIR N/A
- Revenue
- RAPT N/A
- CLIR $4,280,000.00
- Revenue This Year
- RAPT N/A
- CLIR $69.16
- Revenue Next Year
- RAPT N/A
- CLIR $440.76
- P/E Ratio
- RAPT N/A
- CLIR N/A
- Revenue Growth
- RAPT N/A
- CLIR 263.02
- 52 Week Low
- RAPT $0.79
- CLIR $0.62
- 52 Week High
- RAPT $27.35
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- RAPT 43.92
- CLIR 65.50
- Support Level
- RAPT $1.07
- CLIR $1.07
- Resistance Level
- RAPT $1.29
- CLIR $1.45
- Average True Range (ATR)
- RAPT 0.17
- CLIR 0.17
- MACD
- RAPT -0.04
- CLIR 0.01
- Stochastic Oscillator
- RAPT 15.43
- CLIR 68.66
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.